IDH2 and oligodendroglioma: This sign represents a sensitive and specific biomarker to diagnose IDH-mutant 1p/19q codeleted oligodendrogliomas, which benefit from a conservative surgery and show a good response to chemotherapy and radiotherapy and an improved outcome [22].